US SB3733 | 2023-2024 | 118th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on February 5 2024 - 25% progression
Action: 2024-02-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Shandra Eisenga Human Cell and Tissue Product Safety Act

Sponsors


History

DateChamberAction
2024-02-05SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB7188 (Same As) 2024-09-18 - Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 0.

Subjects


US Congress State Sources


Bill Comments

feedback